AMA
Pietrzak A, Dziki A, Banasiewicz T, Reguła J. Cyclic rifaximin therapy effectively prevents
the recurrence of symptoms after exacerbation
of symptomatic uncomplicated diverticular disease: a retrospective study. Gastroenterology Review/Przegląd Gastroenterologiczny. 2019;14(1):69-78. doi:10.5114/pg.2019.83428.
APA
Pietrzak, A., Dziki, A., Banasiewicz, T., & Reguła, J. (2019). Cyclic rifaximin therapy effectively prevents
the recurrence of symptoms after exacerbation
of symptomatic uncomplicated diverticular disease: a retrospective study. Gastroenterology Review/Przegląd Gastroenterologiczny, 14(1), 69-78. https://doi.org/10.5114/pg.2019.83428
Chicago
Pietrzak, Anna M., Adam Dziki, Tomasz Banasiewicz, and Jarosław Reguła. 2019. "Cyclic rifaximin therapy effectively prevents
the recurrence of symptoms after exacerbation
of symptomatic uncomplicated diverticular disease: a retrospective study". Gastroenterology Review/Przegląd Gastroenterologiczny 14 (1): 69-78. doi:10.5114/pg.2019.83428.
Harvard
Pietrzak, A., Dziki, A., Banasiewicz, T., and Reguła, J. (2019). Cyclic rifaximin therapy effectively prevents
the recurrence of symptoms after exacerbation
of symptomatic uncomplicated diverticular disease: a retrospective study. Gastroenterology Review/Przegląd Gastroenterologiczny, 14(1), pp.69-78. https://doi.org/10.5114/pg.2019.83428
MLA
Pietrzak, Anna M. et al. "Cyclic rifaximin therapy effectively prevents
the recurrence of symptoms after exacerbation
of symptomatic uncomplicated diverticular disease: a retrospective study." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 14, no. 1, 2019, pp. 69-78. doi:10.5114/pg.2019.83428.
Vancouver
Pietrzak A, Dziki A, Banasiewicz T, Reguła J. Cyclic rifaximin therapy effectively prevents
the recurrence of symptoms after exacerbation
of symptomatic uncomplicated diverticular disease: a retrospective study. Gastroenterology Review/Przegląd Gastroenterologiczny. 2019;14(1):69-78. doi:10.5114/pg.2019.83428.
